Prostate News Archive
31-Mar-2011
New Therapy for Enlarged Prostate May Bypass Unpleasant Side Effects
Title: New Therapy for Enlarged prostate May Bypass Unpleasant Side Effects Category: Health News Created: 3/29/2011 2:05:00 PM Last Editorial Review: 3/30/2011 Dendreon $93,000-a-Year Prostate Cancer Drug Backed for Medicare Coverage
Dendreon Corp. (DNDN) ?s prostate cancer drug Provenge should be covered by the U.S. government for use in older men, regulators said. The $93,000 drug regimen is ?reasonable and necessary? for men with advanced, castrate-resistant prostate tumors who have minimal or no symptoms of the disease, the Centers for Medicare & Medicaid Services said today in a proposed decision memo. No-Scalpel Treatment for Enlarged Prostate
Title: No-Scalpel Treatment for Enlarged prostate Category: Health News Created: 3/30/2011 11:00:00 AM Last Editorial Review: 3/30/2011
Back to Prostate News Archive
